BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 110 filers reported holding BIONTECH SE in Q2 2020. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $6 | -45.5% | 70 | -41.7% | 0.00% | -50.0% |
| Q1 2024 | $11 | -52.2% | 120 | -45.5% | 0.00% | -55.6% |
| Q4 2023 | $23 | -4.2% | 220 | 0.0% | 0.01% | -10.0% |
| Q3 2023 | $24 | 0.0% | 220 | 0.0% | 0.01% | -9.1% |
| Q2 2023 | $24 | +14.3% | 220 | +29.4% | 0.01% | +22.2% |
| Q1 2023 | $21 | -36.4% | 170 | -22.7% | 0.01% | -47.1% |
| Q4 2022 | $33 | -99.9% | 220 | 0.0% | 0.02% | +13.3% |
| Q3 2022 | $30,000 | -9.1% | 220 | 0.0% | 0.02% | 0.0% |
| Q2 2022 | $33,000 | -13.2% | 220 | 0.0% | 0.02% | +7.1% |
| Q1 2022 | $38,000 | -33.3% | 220 | 0.0% | 0.01% | -30.0% |
| Q4 2021 | $57,000 | +23.9% | 220 | +29.4% | 0.02% | +17.6% |
| Q3 2021 | $46,000 | +21.1% | 170 | 0.0% | 0.02% | +21.4% |
| Q2 2021 | $38,000 | +40.7% | 170 | -32.0% | 0.01% | +40.0% |
| Q1 2021 | $27,000 | +35.0% | 250 | 0.0% | 0.01% | +25.0% |
| Q4 2020 | $20,000 | +100.0% | 250 | +66.7% | 0.01% | +100.0% |
| Q3 2020 | $10,000 | 0.0% | 150 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $10,000 | – | 150 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 148,674 | $11,947,443 | 19.99% |
| Quinn Opportunity Partners LLC | 683,287 | $54,908,943 | 6.24% |
| Krensavage Asset Management, LLC | 132,293 | $10,631 | 4.88% |
| Crocodile Capital Partners GmbH | 29,586 | $2,377,531 | 3.78% |
| ALTRINSIC GLOBAL ADVISORS LLC | 676,219 | $54,340,958 | 2.42% |
| FLOSSBACH VON STORCH AG | 4,379,483 | $351,935,254 | 1.48% |
| Systrade AG | 10,000 | $803,600 | 1.38% |
| HARDING LOEVNER LP | 2,926,761 | $235,224,417 | 1.30% |
| CenterBook Partners LP | 206,234 | $16,572,964 | 1.03% |
| SECTORAL ASSET MANAGEMENT INC | 27,265 | $2,191,015 | 0.89% |